These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 37746290)
1. Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B and RTEL1 genes in glioma: a meta-analysis. Wu Y; Zhou J; Zhang J; Tang Z; Chen X; Huang L; Liu S; Chen H; Wang Y Front Oncol; 2023; 13():1180099. PubMed ID: 37746290 [TBL] [Abstract][Full Text] [Related]
2. Replication of GWAS identifies RTEL1, CDKN2A/B, and PHLDB1 SNPs as risk factors in Portuguese gliomas patients. Viana-Pereira M; Moreno DA; Linhares P; Amorim J; Nabiço R; Costa S; Vaz R; Reis RM Mol Biol Rep; 2020 Feb; 47(2):877-886. PubMed ID: 31721021 [TBL] [Abstract][Full Text] [Related]
3. Association between glioma susceptibility loci and tumour pathology defines specific molecular etiologies. Di Stefano AL; Enciso-Mora V; Marie Y; Desestret V; Labussière M; Boisselier B; Mokhtari K; Idbaih A; Hoang-Xuan K; Delattre JY; Houlston RS; Sanson M Neuro Oncol; 2013 May; 15(5):542-7. PubMed ID: 23161787 [TBL] [Abstract][Full Text] [Related]
4. An Updated and Comprehensive Meta-Analysis of Association Between Seven Hot Loci Polymorphisms from Eight GWAS and Glioma Risk. Wu Q; Peng Y; Zhao X Mol Neurobiol; 2016 Sep; 53(7):4397-405. PubMed ID: 26243184 [TBL] [Abstract][Full Text] [Related]
5. The RTEL1 rs6010620 polymorphism and glioma risk: a meta-analysis based on 12 case-control studies. Du SL; Geng TT; Feng T; Chen CP; Jin TB; Chen C Asian Pac J Cancer Prev; 2014; 15(23):10175-9. PubMed ID: 25556444 [TBL] [Abstract][Full Text] [Related]
6. Effect of CDKN2A/B rs4977756 polymorphism on glioma risk: a meta-analysis of 16 studies including 24077 participants. Qi X; Wan Y; Zhan Q; Yang S; Wang Y; Cai X Mamm Genome; 2016 Feb; 27(1-2):1-7. PubMed ID: 26577493 [TBL] [Abstract][Full Text] [Related]
7. Genome-wide association study identifies five susceptibility loci for glioma. Shete S; Hosking FJ; Robertson LB; Dobbins SE; Sanson M; Malmer B; Simon M; Marie Y; Boisselier B; Delattre JY; Hoang-Xuan K; El Hallani S; Idbaih A; Zelenika D; Andersson U; Henriksson R; Bergenheim AT; Feychting M; Lönn S; Ahlbom A; Schramm J; Linnebank M; Hemminki K; Kumar R; Hepworth SJ; Price A; Armstrong G; Liu Y; Gu X; Yu R; Lau C; Schoemaker M; Muir K; Swerdlow A; Lathrop M; Bondy M; Houlston RS Nat Genet; 2009 Aug; 41(8):899-904. PubMed ID: 19578367 [TBL] [Abstract][Full Text] [Related]
8. Genetic advances in glioma: susceptibility genes and networks. Liu Y; Shete S; Hosking F; Robertson L; Houlston R; Bondy M Curr Opin Genet Dev; 2010 Jun; 20(3):239-44. PubMed ID: 20211558 [TBL] [Abstract][Full Text] [Related]
9. CCDC26 rs4295627 polymorphism and glioma risk: a meta-analysis. Cui T Int J Clin Exp Med; 2015; 8(3):3862-8. PubMed ID: 26064285 [TBL] [Abstract][Full Text] [Related]
10. Interaction between 5 genetic variants and allergy in glioma risk. Schoemaker MJ; Robertson L; Wigertz A; Jones ME; Hosking FJ; Feychting M; Lönn S; McKinney PA; Hepworth SJ; Muir KR; Auvinen A; Salminen T; Kiuru A; Johansen C; Houlston RS; Swerdlow AJ Am J Epidemiol; 2010 Jun; 171(11):1165-73. PubMed ID: 20462933 [TBL] [Abstract][Full Text] [Related]
11. Genetic risk profiles identify different molecular etiologies for glioma. Simon M; Hosking FJ; Marie Y; Gousias K; Boisselier B; Carpentier C; Schramm J; Mokhtari K; Hoang-Xuan K; Idbaih A; Delattre JY; Lathrop M; Robertson LB; Houlston RS; Sanson M Clin Cancer Res; 2010 Nov; 16(21):5252-9. PubMed ID: 20847058 [TBL] [Abstract][Full Text] [Related]
12. Associations between the rs6010620 polymorphism in RTEL1 and risk of glioma: a meta-analysis of 20,711 participants. Wu Y; Tong X; Tang LL; Zhou K; Zhong CH; Jiang S Asian Pac J Cancer Prev; 2014; 15(17):7163-7. PubMed ID: 25227808 [TBL] [Abstract][Full Text] [Related]
13. CCDC26 rs4295627 polymorphisms associated with an increased risk of glioma: A meta-analysis. Zeng J; Luo Y; Yu M; Li J; Liu Z Adv Clin Exp Med; 2017 Nov; 26(8):1275-1281. PubMed ID: 29264887 [TBL] [Abstract][Full Text] [Related]
14. Erratum: Pertinence of glioma and single nucleotide polymorphism of TERT, CCDC26, CDKN2A/B, and RTEL1 genes in glioma: a meta-analysis. Frontiers Production Office Front Oncol; 2024; 14():1393063. PubMed ID: 38529370 [TBL] [Abstract][Full Text] [Related]
15. Genetic risk variants in the CDKN2A/B, RTEL1 and EGFR genes are associated with somatic biomarkers in glioma. Ghasimi S; Wibom C; Dahlin AM; Brännström T; Golovleva I; Andersson U; Melin B J Neurooncol; 2016 May; 127(3):483-92. PubMed ID: 26839018 [TBL] [Abstract][Full Text] [Related]
16. Association of the CCDC26 rs4295627 polymorphism with the risk of glioma: Evidence from 7,290 cases and 11,630 controls. Wang X; Luo T; Ruan M; Liu P; Wang S; Zhu W Mol Clin Oncol; 2016 May; 4(5):878-882. PubMed ID: 27123300 [TBL] [Abstract][Full Text] [Related]
17. CCDC26 rs4295627 polymorphism (8q24.21) and glioma risk: a meta-analysis. Lu HW; Huang M; Wang JH; Sun XL; Ke YQ Genet Mol Res; 2015 Oct; 14(4):12074-84. PubMed ID: 26505354 [TBL] [Abstract][Full Text] [Related]
18. Genetic causes of glioma: new leads in the labyrinth. Melin B Curr Opin Oncol; 2011 Nov; 23(6):643-7. PubMed ID: 21825990 [TBL] [Abstract][Full Text] [Related]
19. New insights into susceptibility to glioma. Liu Y; Shete S; Hosking FJ; Robertson LB; Bondy ML; Houlston RS Arch Neurol; 2010 Mar; 67(3):275-8. PubMed ID: 20212223 [TBL] [Abstract][Full Text] [Related]
20. CCDC26, CDKN2BAS, RTEL1 and TERT Polymorphisms in pediatric brain tumor susceptibility. Adel Fahmideh M; Lavebratt C; Schüz J; Röösli M; Tynes T; Grotzer MA; Johansen C; Kuehni CE; Lannering B; Prochazka M; Schmidt LS; Feychting M Carcinogenesis; 2015 Aug; 36(8):876-82. PubMed ID: 26014354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]